<unk>  is an ethanol dependency that is FDA approved for the treatment of maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.   Common adverse reactions include accidental injury, asthenia, pain, anorexia, diarrhea, flatulence, nausea, anxiety, depression, dizziness, dry mouth, insomnia, paresthesia, pruritus and sweating..
Acamprosate calcium
Divalproex sodium
Valproate sodium
Retigabine
Clorazepate Dipotassium
Flurazepam hydrochloride
Carisbamate
Butamirate